VIRI Insider Trading

Insider Ownership Percentage: 11.70%
Insider Buying (Last 12 Months): $51,185.50
Insider Selling (Last 12 Months): $0.00

Virios Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Virios Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Virios Therapeutics Share Price & Price History

Current Price: $0.46
Price Change: Price Decrease of -0.011 (-2.34%)
As of 04/16/2024 09:54 AM ET

This chart shows the closing price history over time for VIRI up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Virios Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/21/2023William PridgenDirectorBuy15,335$1.30$19,935.5052,045View SEC Filing Icon  
8/17/2023Gregory Scott DuncanCEOBuy25,000$1.25$31,250.0057,461View SEC Filing Icon  
12/8/2022Richard James WhitleyDirectorSell1,800$0.26$468.00700View SEC Filing Icon  
5/23/2022Angela WalshSVPBuy2,000$4.58$9,160.003,000View SEC Filing Icon  
5/23/2022Gregory Scott DuncanCEOBuy7,500$4.52$33,900.0032,461View SEC Filing Icon  
5/17/2022William PridgenDirectorBuy13,450$4.38$58,911.0036,469View SEC Filing Icon  
3/29/2022William PridgenDirectorBuy600$4.94$2,964.00View SEC Filing Icon  
3/23/2022William PridgenDirectorBuy2,197$5.46$11,995.62View SEC Filing Icon  
1/27/2022William PridgenDirectorBuy4,180$5.98$24,996.40View SEC Filing Icon  
1/6/2022Richard James WhitleyDirectorBuy1,800$5.72$10,296.00View SEC Filing Icon  
12/23/2021Richard James WhitleyDirectorBuy200$5.72$1,144.00View SEC Filing Icon  
12/21/2021Gregory Scott DuncanCEOBuy5,000$5.52$27,600.00View SEC Filing Icon  
12/21/2021William PridgenDirectorBuy8,827$5.66$49,960.82View SEC Filing Icon  
7/7/2021William PridgenDirectorBuy942$6.32$5,953.44View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Virios Therapeutics (NASDAQ:VIRI)

9.05% of Virios Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at VIRI by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Virios Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/15/2023Citadel Advisors LLC33,298$46K0.0%N/A0.182%Search for SEC Filing on Google Icon
8/14/2023State Street Corp52,828$73K0.0%+397.1%0.289%Search for SEC Filing on Google Icon
8/11/2023Geode Capital Management LLC147,269$0.20M0.0%+144.3%0.805%Search for SEC Filing on Google Icon
8/8/2023Belvedere Trading LLC18,142$25K0.0%N/A0.099%Search for SEC Filing on Google Icon
7/28/2023McCollum Christoferson Group LLC30,700$42K0.0%N/A0.168%Search for SEC Filing on Google Icon
5/16/2023Susquehanna International Group LLP161,811$59K0.0%+343.3%1.943%Search for SEC Filing on Google Icon
5/11/2023Envestnet Asset Management Inc.120,663$44K0.0%+10.5%1.449%Search for SEC Filing on Google Icon
2/13/2023Renaissance Technologies LLC235,400$56K0.0%+33.3%2.826%Search for SEC Filing on Google Icon
2/7/2023Envestnet Asset Management Inc.109,196$26K0.0%+576.3%1.311%Search for SEC Filing on Google Icon
11/14/2022Renaissance Technologies LLC176,600$67K0.0%N/A2.120%Search for SEC Filing on Google Icon
11/7/2022Warberg Asset Management LLC200,000$74K0.0%N/A2.401%Search for SEC Filing on Google Icon
10/13/2022PVG Asset Management Corp80,590$31K0.1%N/A0.967%Search for SEC Filing on Google Icon
8/15/2022State Street Corp10,628$45K0.0%N/A0.128%Search for SEC Filing on Google Icon
7/12/2022Koshinski Asset Management Inc.40,924$0.17M0.0%N/A0.491%Search for SEC Filing on Google Icon
7/6/2022Wiley BROS. Aintree Capital LLC11,000$47K0.0%N/A0.132%Search for SEC Filing on Google Icon
5/16/2022UBS Group AG14,137$63K0.0%+528.3%0.170%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.241,666$1.08M0.0%+63.4%2.901%Search for SEC Filing on Google Icon
5/12/2022Cetera Advisors LLC43,944$0.20M0.0%+22.0%0.528%Search for SEC Filing on Google Icon
11/16/2021Captrust Financial Advisors40,145$0.21M0.0%N/A0.482%Search for SEC Filing on Google Icon
11/16/2021Cetera Advisors LLC48,432$0.26M0.0%+100.0%0.581%Search for SEC Filing on Google Icon
11/16/2021Masters Capital Management LLC650,000$3.44M0.1%+8.3%7.803%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.15,856$84K0.0%+64.3%0.190%Search for SEC Filing on Google Icon
9/17/2021Virtu Financial LLC13,110$82K0.0%N/A0.157%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC18,499$0.12M0.0%N/A0.222%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.141,011$0.89M0.0%N/A1.693%Search for SEC Filing on Google Icon
5/18/2021Millennium Management LLC22,858$0.13M0.0%+10.4%0.274%Search for SEC Filing on Google Icon
5/17/2021Masters Capital Management LLC600,000$3.44M0.1%+33.9%7.203%Search for SEC Filing on Google Icon
5/14/2021PVG Asset Management Corp55,160$0.32M1.0%N/A0.662%Search for SEC Filing on Google Icon
5/4/2021Envestnet Asset Management Inc.27,844$0.16M0.0%N/A0.334%Search for SEC Filing on Google Icon
2/24/2021Virtu Financial LLC35,219$0.26M0.0%N/A0.450%Search for SEC Filing on Google Icon
2/17/2021Jane Street Group LLC95,230$0.72M0.0%N/A1.216%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Virios Therapeutics logo
Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It also develops IMC-2, a combination of valacyclovir and celecoxib for the treatment of managing the fatigue, sleep, attention, pain, autonomic function, and anxiety associated with long COVID. The company was formerly known as Innovative Med Concepts, LLC and changed its name to Virios Therapeutics, Inc. in July 2020. Virios Therapeutics, Inc. was founded in 2012 and is headquartered in Alpharetta, Georgia.
Read More on Virios Therapeutics

Today's Range

Now: $0.46
Low: $0.46
High: $0.46

50 Day Range

MA: $0.40
Low: $0.31
High: $0.58

52 Week Range

Now: $0.46
Low: $0.28
High: $2.42

Volume

10,852 shs

Average Volume

369,242 shs

Market Capitalization

$8.86 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.88

Who are the company insiders with the largest holdings of Virios Therapeutics?

Virios Therapeutics' top insider investors include:
  1. Gregory Scott Duncan (CEO)
  2. William Pridgen (Director)
  3. Angela Walsh (SVP)
  4. Richard James Whitley (Director)
Learn More about top insider investors at Virios Therapeutics.